Serprozyme ApS: Financial statements 2024
CVR: 44083205
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Serprozyme ApS (CVR 44083205) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 31,033 and a net result of DKK 24,507. Equity in the 2024 report amounted to DKK 62,321. The solvency ratio was 90.1%.
- Gross Profit
- DKK 31,033
- Profit/Loss
- DKK 24,507
- Equity
- DKK 62,321
- Total Assets
- DKK 69,141
- Employees
- 0
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Serprozyme ApS has published its interim report for the period May 26, 2023 – December 31, 2023.
About Serprozyme ApS
Serprozyme ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jan Kristian Jensen. The company is owned by Emvijo Initiative ApS and Jan Kristian Jensen Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 168,506 and a net result of DKK 131,445 compared with DKK 24,507 the year before. Equity in the 2025 report amounted to DKK 193,766.